What Researchers Did
Researchers reviewed extensive data from preclinical and human trials on supplemental inhaled, hyperbaric, and topical oxygen treatments for wound healing.
What They Found
They found that wound hypoxia is more prevalent than generally appreciated, even in patients without arterial occlusive disease. Extensive preclinical and human trial data demonstrate a strong scientific basis for oxygen treatment as prophylaxis against infection, to facilitate wound closure, and to prevent amputation.
What This Means for Canadian Patients
Canadian patients suffering from chronic wounds or at risk of infection could potentially benefit from oxygen therapies to improve healing outcomes. These treatments may help prevent complications like amputation and accelerate wound closure, improving quality of life.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor does it specifically address Canadian healthcare contexts or patient populations.
Study Limitations
As a review article, this study synthesizes existing data but does not present new primary research findings or address potential biases within the reviewed literature.